The IDH1 mutation impeded the maturation of astrocytes with low OGDH, but we found that it did not alter the expression of GFAP, Nestin, CD133, and CD44 in U87 and U251 glioma cells (Fig. 6a). This evidence concerns the gene CD44 and central nervous system cancer.